Lv4
770 积分 2025-05-23 加入
225Ac-PSMA-617-Augmentation nach unzureichendem Ansprechen unter 177Lu-PSMA-617-Radioligandentherapie bei mCRPC
2个月前
已完结
Artifacts and Pitfalls in Ga-68 PET imaging
7个月前
已关闭
Effectiveness of Quenchers to Reduce Radiolysis of 111In- or 177Lu-Labelled Methionine-Containing Regulatory Peptides. Maintaining Radiochemical Purity as Measured by HPLC
9个月前
已完结
Theranostics in Neuroendocrine Tumors
9个月前
已完结
Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes 203Pb and 212Pb
11个月前
已完结
Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models
1年前
已完结
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors
1年前
已完结
Synthesis of 225Ac-PSMA-617 for Preclinical Use
1年前
已完结
Synthesis and preliminary evaluation of [225Ac]Ac‑LNC1011 for targeted α-radionuclide therapy of prostate cancer
1年前
已关闭
Development of [225Ac]Ac‑LNC1011 for targeted alpha-radionuclide therapy of prostate cancer
1年前
已完结
皖公网安备34019202002308
